Page last updated: 2024-08-26

fructose 2,6-diphosphate and Adenocarcinoma

fructose 2,6-diphosphate has been researched along with Adenocarcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ke, H; Li, X; Liu, J; Liu, Y; Qian, L; Tian, W; Yao, C; Zhang, J1
Chesney, J; Clark, J; Imbert-Fernandez, Y; Klarer, AC; Lane, AN; Telang, S1
Babia, T; Bosch, F; Denis-Pouxviel, C; Gomez-Foix, AM; Guinovart, JJ; Murat, JC; Trocheris, V1
Denis, C; Murat, JC; Paris, H1
Denis, C; Murat, JC; Paris, H; Trocheris, V1

Other Studies

5 other study(ies) available for fructose 2,6-diphosphate and Adenocarcinoma

ArticleYear
Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
    Molecular and cellular biochemistry, 2018, Volume: 445, Issue:1-2

    Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Female; Fructosediphosphates; Glucose; Glycolysis; Humans; Ki-67 Antigen; Lactic Acid; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Phosphofructokinase-2; Pyridines; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Tissue Array Analysis

2018
Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.
    Oncotarget, 2014, Aug-30, Volume: 5, Issue:16

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Female; Fructosediphosphates; Glucose; Glycolysis; HCT116 Cells; Heterografts; Humans; Lung Neoplasms; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Oxidation-Reduction; Phosphofructokinase-2; Phosphorylation

2014
Insulin controls key steps of carbohydrate metabolism in cultured HT29 colon cancer cells.
    The Biochemical journal, 1989, Jul-01, Volume: 261, Issue:1

    Topics: Adenocarcinoma; Colonic Neoplasms; Fructosediphosphates; Glucose; Glycogen; Glycogen Synthase; Glycolysis; Humans; Insulin; Lactates; Phosphorylases; Tumor Cells, Cultured

1989
Hormonal control of fructose 2,6-bisphosphate concentration in the HT29 human colon adenocarcinoma cell line. Alpha 2-adrenergic agonists counteract effect of vasoactive intestinal peptide.
    The Biochemical journal, 1986, Nov-01, Volume: 239, Issue:3

    Topics: Adenocarcinoma; Brimonidine Tartrate; Cell Line; Clonidine; Colonic Neoplasms; Cyclic AMP; Epinephrine; Fructosediphosphates; Hexosediphosphates; Humans; Quinoxalines; Vasoactive Intestinal Peptide; Yohimbine

1986
Variations of fructose-2,6-diphosphate levels in cultured HT29 human colon cancer cells: influence of hexoses and lactate concentrations.
    The International journal of biochemistry, 1986, Volume: 18, Issue:12

    Topics: Adenocarcinoma; Cell Line; Colonic Neoplasms; Fructosediphosphates; Glucose; Hexosediphosphates; Humans; Kinetics; Lactates

1986